Schedule 13G ownership disclosure
Arcellx Inc
Common Stock, $0.001 par value per share · CUSIP: 03940C100
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Paradigm BioCapital Advisors LP
Shares: 5,724,016.00 · Class: 9.9%
- Paradigm BioCapital Advisors GP LLC
Shares: 5,724,016.00 · Class: 9.9%
- Senai Asefaw, M.D.
Shares: 5,724,016.00 · Class: 9.9%
- Paradigm BioCapital International Fund Ltd.
Shares: 5,055,581.00 · Class: 8.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-016366
- Form type
- SCHEDULE 13G/A
- Filer
- Arcellx, Inc.
- CIK
- CIK 1786205
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership